Related Experiment Videos

Nutritional supplements with intravenously administered lipid, protein hydrolysate, and glucose in small premature

Pediatrics
|July 1, 1975
PubMed

Insights

Intravenous nutrition, including lipids, supported growth in premature infants. Some infants experienced temporary intolerance, but autopsies showed no lipid-related harm, suggesting a useful role for intravenous fat in neonatal nutrition.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Intensive Care Medicine

Background:

  • Premature infants (<1,500 gm) require specialized nutritional support for optimal growth.
  • Intravenous (IV) administration of nutrients is crucial when enteral feeding is not feasible.
  • The role of IV lipids in the nutritional management of very low birth weight infants warrants further investigation.

Purpose of the Study:

  • To evaluate the efficacy and safety of intravenous nutritional support, including lipids, in premature infants.
  • To assess the impact of this nutritional regimen on infant growth.
  • To identify potential complications associated with IV nutrient administration in this vulnerable population.

Main Methods:

  • Twenty-three premature infants (birth weight <1,500 gm) received nutritional support via IV fat, protein hydrolysate, and glucose.
  • Infant growth was monitored and compared to intrauterine growth rates.
  • Complications and adverse events were systematically recorded.

Main Results:

  • Growth in the 19 surviving infants approximated intrauterine growth rates across all dimensions.
  • Sodium imbalance and transient intolerance to various nutrient components (carbohydrate, protein, fat, water) were observed in some infants.
  • Autopsies of four non-survivors revealed no significant findings directly attributable to the intravenously administered lipids.

Conclusions:

  • Intravenous nutritional support, incorporating lipids, can promote growth in premature infants comparable to intrauterine rates.
  • While transient intolerance can occur, particularly in the sickest infants, IV lipids appear safe for use in this population.
  • Intravenously administered fat holds potential as a valuable component of nutritional support for small premature infants.

Related Concept Videos